ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021:

Follow this link:
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *